Pulmonary Embolism Unplugged: Catheter-Directed Therapies for Intermediate-Risk Pulmonary Embolism

Leben Tefera; Khaled M Ziada; Scott J Cameron

doi:10.1016/j.jcin.2023.08.029

Pulmonary Embolism Unplugged: Catheter-Directed Therapies for Intermediate-Risk Pulmonary Embolism

JACC Cardiovasc Interv. 2023 Nov 13;16(21):2652-2654. doi: 10.1016/j.jcin.2023.08.029. Epub 2023 Oct 18.

Authors

Leben Tefera¹, Khaled M Ziada², Scott J Cameron³

Affiliations

¹ Department of Cardiovascular Medicine, Section of Vascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
² Department of Cardiovascular Medicine, Section of Interventional Cardiology, Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
³ Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute of Case Western Reserve University, Cleveland, Ohio, USA; Department of Hematology, Taussig Cancer Institute, Cleveland, Ohio, USA; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA. Electronic address: cameros3@ccf.org.

PMID: 37855803
DOI: 10.1016/j.jcin.2023.08.029

No abstract available

Keywords: catheter-directed therapy; chronic thromboembolic disease; chronic thromboembolic pulmonary hypertension; pulmonary embolism; systemic thrombolysis.

Publication types

Editorial
Comment

MeSH terms

Catheters
Fibrinolytic Agents / therapeutic use
Humans
Pulmonary Embolism* / drug therapy
Pulmonary Embolism* / therapy
Thrombolytic Therapy / adverse effects
Treatment Outcome

Substances

Fibrinolytic Agents